Immutep IMMP
NASDAQ IMMP
$0.36 -0.01 (-2.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immutep (IMMP) Receivables (2011 - 2026)

Immutep's (IMMP) quarterly Receivables came in at $6.7 million in Q2 2026, up 5.62% on a YoY basis from $6.3 million in Q2 2025, and down 72.32% quarter-over-quarter from $24.1 million in Q4 2025.

Analysis

Immutep (IMMP) Receivables (2011 - 2026) Analysis & Trends

Immutep (IMMP) has reported Receivables for 16 consecutive years, with $6.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Receivables rose 5.62% year-over-year to $6.7 million; the trailing twelve-month figure through Jun 2026 stood at $6.7 million (up 5.62% YoY), and the FY2026 full-year result was $6.7 million, up 5.62% from the prior year.
  • Receivables retreated to $6.7 million in Q2 2026 per IMMP's latest filing, from $24.1 million in the prior quarter.
  • Across five years, Receivables topped out at $24.1 million in Q4 2025 and bottomed at $3.3 million in Q4 2022.
  • Historically, Receivables has averaged $7.2 million across 5 years, with a median of $5.3 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Receivables slumped 35.35% in 2022, then jumped 439.65% in 2025.
  • Over 5 years, Receivables stood at $3.3 million in 2022, then climbed by 21.06% to $4.0 million in 2023, then climbed by 12.48% to $4.5 million in 2024, then surged by 439.65% to $24.1 million in 2025, then slumped by 72.32% to $6.7 million in 2026.
  • According to Business Quant data, Receivables over the past three periods registered $6.7 million, $24.1 million, and $6.3 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 10.23 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 5.90 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 2.13 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 6.57 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.93 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 160.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 912.74 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 1.89 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Immutep 51.68 Mn 51.68 Mn - 6.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.68 Mn
Dec 31, 2025 24.11 Mn
Jun 30, 2025 6.32 Mn
Dec 31, 2024 4.47 Mn
Jun 30, 2024 4.84 Mn
Dec 31, 2023 3.97 Mn
Jun 30, 2023 5.31 Mn
Dec 31, 2022 3.28 Mn
Jun 30, 2022 6.00 Mn
Dec 31, 2021 5.08 Mn
Jun 30, 2021 4.72 Mn
Dec 31, 2020 3.88 Mn
Jun 30, 2020 2.16 Mn
Dec 31, 2019 3.24 Mn
Jun 30, 2019 3.64 Mn
Jun 30, 2018 2.60 Mn
Dec 31, 2017 2.92 Mn
Jun 30, 2017 1.65 Mn
Mar 31, 2017 1.77 Mn
Dec 31, 2016 1.60 Mn